研究發現常見止痛藥對嬰兒是安全的
Study finds common pain relievers safe for infants
Updated at: August 7, 2026 at 12:30 AM
對於父母而言，管理嬰兒的發燒或疼痛可能是焦慮的重大來源，尤其是在決定哪種藥物可以安全使用時。
For parents, managing an infant's fever or pain can be a source of significant anxiety, especially when deciding which medication is safe to use.
紐西蘭一項涉及近四千名嬰兒的具里程碑意義的臨床試驗提供了期盼已久的保證。
A landmark clinical trial involving nearly 4,000 babies in New Zealand has provided long-awaited reassurance.
研究人員比較了乙醯胺酚和布洛芬在生命第一年內的安全概況，結果很明確：這兩種藥物對嬰兒的安全性相當。
Researchers compared the safety profiles of acetaminophen and ibuprofen during the first year of life, and the results are clear: both medications are equally safe for infants.
然而，這項大規模、隨機對照試驗未發現任何此類風險的證據。
However, this large-scale, randomized controlled trial found no evidence of such risks.
乙醯胺酚組中約有16%的嬰兒患有濕疹，而布洛芬組則為15%，細支氣管炎的比率兩組皆約為5%，顯示無顯著差異。
Approximately 16% of babies in the acetaminophen group and 15% in the ibuprofen group developed eczema, while bronchiolitis rates were about 5% in both, showing no significant difference.
主導研究人員史都阿爾齊教授指出，這些發現使父母和醫療提供者在必要時使用這些藥物時更具信心。
Lead researcher Professor Stuart Dalziel noted that the findings give parents and healthcare providers high confidence in using these medications when necessary.
研究人員將繼續追蹤這些兒童至六歲，以監測長期影響，包括氣喘和神經發育健康，以確保給家庭的指導始終基於最佳證據。
Researchers will continue tracking these children until age six to monitor long-term outcomes, including asthma and neurodevelopmental health, ensuring that the guidance for families remains based on the best possible evidence.
